ORCID as entered in ROS

Select Publications
2025, 'Motor-Free Soft Robots for Cancer Detection, Surgery, and In Situ Bioprinting', Advanced Healthcare Materials, 14, http://dx.doi.org/10.1002/adhm.202404623
,2025, 'Abstract 2705: Spatial profiling of tumor microenvironment uncovers potential novel therapeutic approach in pediatric neuroblastoma', Cancer Research, 85, pp. 2705 - 2705, http://dx.doi.org/10.1158/1538-7445.am2025-2705
,2025, 'CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers', Oncogene, 44, pp. 893 - 908, http://dx.doi.org/10.1038/s41388-024-03259-y
,2025, 'Correction to: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers (Oncogene, (2025), 44, 13, (893-908), 10.1038/s41388-024-03259-y)', Oncogene, 44, pp. 927, http://dx.doi.org/10.1038/s41388-025-03319-x
,2025, 'Germline analysis of an international cohort of pediatric diffuse midline glioma patients.', Neuro Oncol, http://dx.doi.org/10.1093/neuonc/noaf061
,2025, 'Cuproplasia-related gene signature: Prognostic insights for glioma therapy', Neuro Oncology Advances, 7, http://dx.doi.org/10.1093/noajnl/vdae233
,2025, 'A phase 1 trial of the FACT inhibitor CBL0137 in pediatric patients with relapsed or refractory solid and CNS tumors: A report from the Children’s Oncology Group study PEPN2111.', Journal of Clinical Oncology, 43, pp. 10051 - 10051, http://dx.doi.org/10.1200/jco.2025.43.16_suppl.10051
,2025, 'Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.', Clin Transl Med, 15, pp. e70140, http://dx.doi.org/10.1002/ctm2.70140
,2025, 'Motor‐Free Soft Robots for Cancer Detection, Surgery, and In Situ Bioprinting (Adv. Healthcare Mater. 14/2025)', Advanced Healthcare Materials, 14, http://dx.doi.org/10.1002/adhm.202570083
,2024, 'Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma', Nature Communications, 15, pp. 10462, http://dx.doi.org/10.1038/s41467-024-54689-x
,2024, 'A novel network-based method identifies a cuproplasia-related pan-cancer gene signature to predict patient outcome', Human Genetics, 143, pp. 1145 - 1162, http://dx.doi.org/10.1007/s00439-024-02673-2
,2024, 'Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain', ACS Sensors, 9, pp. 2858 - 2868, http://dx.doi.org/10.1021/acssensors.3c02549
,2024, 'Dual-responsive chondroitin sulfate self-assembling nanoparticles for combination therapy in metastatic cancer cells', International Journal of Pharmaceutics X, 7, http://dx.doi.org/10.1016/j.ijpx.2024.100235
,2024, 'Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells', Nanoscale Horizons, 9, pp. 1211 - 1218, http://dx.doi.org/10.1039/d4nh00042k
,2024, 'Abstract 3056: Copper chelation modulates YTHDF2 RNA-binding protein localization and global translation, in neuronal cancers', Cancer Research, 84, pp. 3056 - 3056, http://dx.doi.org/10.1158/1538-7445.am2024-3056
,2024, 'Abstract 3636: Myeloid cell rebound associated with GD2-CAR-T cell therapy in solid tumor patients', Cancer Research, 84, pp. 3636 - 3636, http://dx.doi.org/10.1158/1538-7445.am2024-3636
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202300360
,2024, 'A road map for the treatment of pediatric diffuse midline glioma', Cancer Cell, 42, pp. 1 - 5, http://dx.doi.org/10.1016/j.ccell.2023.11.002
,2024, 'In Vivo Behavior of Systemically Administered Encapsulin Protein Nanocages and Implications for their use in Targeted Drug Delivery (Adv. Therap. 2/2024)', Advanced Therapeutics, 7, http://dx.doi.org/10.1002/adtp.202470003
,2023, 'A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer', Genome Medicine, 15, http://dx.doi.org/10.1186/s13073-023-01170-x
,2023, 'Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer', Cell and Bioscience, 13, pp. 132, http://dx.doi.org/10.1186/s13578-023-01083-7
,2023, 'Evolving approaches in glioma treatment: harnessing the potential of copper metabolism modulation', Rsc Advances, 13, pp. 34045 - 34056, http://dx.doi.org/10.1039/d3ra06434d
,2023, 'Evaluating the Efficiency of Chitosan-Graphene Oxide Hybrid Hydrogels as Drug Delivery Systems', Macromolecular Materials and Engineering, 308, http://dx.doi.org/10.1002/mame.202300166
,2023, 'Endogenous PP2A inhibitor CIP2A degradation by chaperone-mediated autophagy contributes to the antitumor effect of mitochondrial complex I inhibition', Cell Reports, 42, http://dx.doi.org/10.1016/j.celrep.2023.112616
,2023, 'Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm', Antibiotics, 12, pp. 585, http://dx.doi.org/10.3390/antibiotics12030585
,2023, 'Q1291H-CFTR molecular dynamics simulations and ex vivo theratyping in nasal epithelial models and clinical response to elexacaftor/tezacaftor/ivacaftor in a Q1291H/F508del patient', Frontiers in Molecular Biosciences, 10, http://dx.doi.org/10.3389/fmolb.2023.1148501
,2022, 'GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma', Journal for Immunotherapy of Cancer, 10, http://dx.doi.org/10.1136/jitc-2022-005187
,2022, 'Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy', Nanomaterials, 12, http://dx.doi.org/10.3390/nano12162851
,2022, 'Curcumin and Graphene Oxide Incorporated into Alginate Hydrogels as Versatile Devices for the Local Treatment of Squamous Cell Carcinoma', Materials, 15, pp. 1648, http://dx.doi.org/10.3390/ma15051648
,2021, 'Tp53 mutation is a prognostic factor in lower grade glioma and may influence chemotherapy efficacy', Cancers, 13, pp. 5362, http://dx.doi.org/10.3390/cancers13215362
,2021, 'Copper: An Intracellular Achilles’ Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics', Chemmedchem, 16, pp. 2315 - 2329, http://dx.doi.org/10.1002/cmdc.202100172
,2021, 'Dextran‐curcumin nanosystems inhibit cell growth and migration regulating the epithelial to mesenchymal transition in prostate cancer cells', International Journal of Molecular Sciences, 22, http://dx.doi.org/10.3390/ijms22137013
,2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, 35, pp. 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994
,2021, 'Alginate bioconjugate and graphene oxide in multifunctional hydrogels for versatile biomedical applications', Molecules, 26, pp. 1355, http://dx.doi.org/10.3390/molecules26051355
,2021, 'Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma', Cancers, 13, pp. 1 - 20, http://dx.doi.org/10.3390/cancers13061278
,2021, 'Carbon Nanohorns as Effective Nanotherapeutics in Cancer Therapy', C-JOURNAL OF CARBON RESEARCH, 7, http://dx.doi.org/10.3390/c7010003
,2020, 'DIPG-83. USING COPPER CHELATING AGENTS TO TARGET RECEPTOR TYROSINE KINASE SIGNALLING IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', Neuro-Oncology, 22, pp. iii303 - iii303, http://dx.doi.org/10.1093/neuonc/noaa222.124
,2020, 'Natural polysaccharide carriers in brain delivery: Challenge and perspective', Pharmaceutics, 12, http://dx.doi.org/10.3390/pharmaceutics12121183
,2020, 'Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion', Cancer Research, 80, pp. 4129 - 4144, http://dx.doi.org/10.1158/0008-5472.CAN-20-0471
,2020, 'Functionalized carbon nanostructures versus drug resistance: Promising scenarios in cancer treatment', Molecules, 25, http://dx.doi.org/10.3390/molecules25092102
,2020, 'Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivation', Theranostics, 10, pp. 6411 - 6429, http://dx.doi.org/10.7150/thno.42602
,2020, 'Dextran-curcumin nanoparticles as a methotrexate delivery vehicle: A step forward in breast cancer combination therapy', Pharmaceuticals, 13, pp. 2, http://dx.doi.org/10.3390/ph13010002
,2019, 'Poor dietary polyphenol intake in childhood cancer patients', Nutrients, 11, http://dx.doi.org/10.3390/nu11112835
,2019, 'Combining carbon nanotubes and chitosan for the vectorization of methotrexate to lung cancer cells', Materials, 12, http://dx.doi.org/10.3390/ma12182889
,2019, 'Magnetic graphene oxide nanocarrier for targeted delivery of cisplatin: A perspective for glioblastoma treatment', Pharmaceuticals, 12, http://dx.doi.org/10.3390/ph12020076
,2019, 'Chitosan–Quercetin Bioconjugate as Multi-Functional Component of Antioxidants and Dual-Responsive Hydrogel Networks', Macromolecular Materials and Engineering, 304, http://dx.doi.org/10.1002/mame.201800728
,2019, 'Combining antioxidant hydrogels with self-assembled microparticles for multifunctional wound dressings', Journal of Materials Chemistry B, 7, pp. 4361 - 4370, http://dx.doi.org/10.1039/c9tb00871c
,2019, 'Graphene oxide functional nanohybrids with magnetic nanoparticles for improved vectorization of doxorubicin to neuroblastoma cells', Pharmaceutics, 11, http://dx.doi.org/10.3390/pharmaceutics11010003
,2019, 'Synthesis of dextran–phenoxodiol and evaluation of its physical stability and biological activity', Frontiers in Bioengineering and Biotechnology, 7, http://dx.doi.org/10.3389/fbioe.2019.00183
,2019, 'When polymers meet carbon nanostructures: Expanding horizons in cancer therapy', Future Medicinal Chemistry, 11, pp. 2205 - 2231, http://dx.doi.org/10.4155/fmc-2018-0540
,